BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28600477)

  • 1. Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer.
    Prieur A; Cappellini M; Habif G; Lefranc MP; Mazard T; Morency E; Pascussi JM; Flacelière M; Cahuzac N; Vire B; Dubuc B; Durochat A; Liaud P; Ollier J; Pfeiffer C; Poupeau S; Saywell V; Planque C; Assenat E; Bibeau F; Bourgaux JF; Pujol P; Sézeur A; Ychou M; Joubert D
    Clin Cancer Res; 2017 Sep; 23(17):5267-5280. PubMed ID: 28600477
    [No Abstract]   [Full Text] [Related]  

  • 2. WNT/β-Catenin Signaling Inhibitor IC-2 Suppresses Sphere Formation and Sensitizes Colorectal Cancer Cells to 5-Fluorouracil.
    Urushibara S; Tsubota T; Asai R; Azumi J; Ashida K; Fujiwara Y; Shiota G
    Anticancer Res; 2017 Aug; 37(8):4085-4091. PubMed ID: 28739692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like Cells.
    Giraud J; Failla LM; Pascussi JM; Lagerqvist EL; Ollier J; Finetti P; Bertucci F; Ya C; Gasmi I; Bourgaux JF; Prudhomme M; Mazard T; Ait-Arsa I; Houhou L; Birnbaum D; Pélegrin A; Vincent C; Ryall JG; Joubert D; Pannequin J; Hollande F
    Cancer Res; 2016 Jun; 76(12):3618-28. PubMed ID: 27197176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
    Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
    Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
    Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
    Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
    Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
    Kim MS; Cho HI; Yoon HJ; Ahn YH; Park EJ; Jin YH; Jang YK
    Sci Rep; 2018 Apr; 8(1):6611. PubMed ID: 29700375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1
    Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G
    Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling.
    Hwang JH; Yoon J; Cho YH; Cha PH; Park JC; Choi KY
    Int J Cancer; 2020 May; 146(10):2877-2890. PubMed ID: 31605540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C; Zhu X
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenethyl isothiocyanate inhibits colorectal cancer stem cells by suppressing Wnt/β-catenin pathway.
    Chen Y; Li Y; Wang XQ; Meng Y; Zhang Q; Zhu JY; Chen JQ; Cao WS; Wang XQ; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
    Phytother Res; 2018 Dec; 32(12):2447-2455. PubMed ID: 30159926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.
    Pietrantonio F; Vernieri C; Siravegna G; Mennitto A; Berenato R; Perrone F; Gloghini A; Tamborini E; Lonardi S; Morano F; Picciani B; Busico A; Volpi CC; Martinetti A; Battaglin F; Bossi I; Pellegrinelli A; Milione M; Cremolini C; Di Bartolomeo M; Bardelli A; de Braud F
    Clin Cancer Res; 2017 May; 23(10):2414-2422. PubMed ID: 27780856
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness.
    Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS
    Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway.
    Chen Y; Wang XQ; Zhang Q; Zhu JY; Li Y; Xie CF; Li XT; Wu JS; Geng SS; Zhong CY; Han HY
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The wnt target jagged-1 mediates the activation of notch signaling by progastrin in human colorectal cancer cells.
    Pannequin J; Bonnans C; Delaunay N; Ryan J; Bourgaux JF; Joubert D; Hollande F
    Cancer Res; 2009 Aug; 69(15):6065-73. PubMed ID: 19622776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
    Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
    BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.